McLaughlin Gerald W. 4
4 · Neos Therapeutics, Inc. · Filed Mar 4, 2020
Insider Transaction Report
Form 4
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-03-02+395,000→ 395,000 totalExercise: $1.49Exp: 2030-03-02→ Common Stock (395,000 underlying) - Award
Common Stock
2020-03-02+290,000→ 314,500 total
Footnotes (2)
- [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in two equal, annual installments beginning on March 2, 2021.
- [F2]This stock option will vest in four equal, annual installments beginning on March 2, 2021.